Loading company…
Synta Pharmaceuticals Corp. develops small molecule drugs for cancer and chronic inflammatory diseases.
Founded in 2001 and based in Lexington, Massachusetts, US, Synta Pharmaceuticals Corp. is a biopharmaceutical company that discovers, develops and commercializes small molecule drugs for severe medical conditions, including cancer and chronic inflammatory diseases. The company is at the Series D stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in